Banyan Readies For Pivotal Study Of Molecular Dx For Traumatic Brain Injury
This article was originally published in The Gray Sheet
Executive Summary
Banyan Biomarkers blood-based assay works by detecting the presence of two proteins that only cross the blood-brain barrier if there’s been a brain injury. An IDE was filed July 2 and the firm hopes for PMA approval in 2014.